3. Results
This study was completed between 21 December 2018, and 25 October 2019, at two clinical sites in Korea. Of 105 people screened, 5 did not meet eligibility criteria, and 100 participants were randomized to FP-MD (n = 50) or placebo (n = 50) (safety set, 